U of M researchers find 2 units of umbilical cord blood reduce risk of leukemia recurrence
(University of Minnesota) A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease returning. This finding has the potential to change the current medical practice of using one unit of UCB for treatment of patients who are at high risk for recurrence of leukemia and other cancers of the blood and bone marrow.
source : www.eurekalert.org
Related News:
- SSRI and Tamoxifen Increase Mortality Risk (CME/CE)
- HRT Linked to Asthma Risk (CME/CE)
- Older Women with Gout at Risk of MI (CME/CE)
- Exercise Program Associated With Denser Bones, Lower Fall Risk In Older Women
- Kaiser Study Compares Two AMD Treatments; "Eye Stroke" Prevalent Worldwide; New Data On Vision And Elders’ Risk Of Falling
- ICAO: Future Chronic Disease Risk Goes Beyond BMI (CME/CE)
- Immune Cells Point to Skin Cancer Risk after Transplants (CME/CE)
- ‘Silent Strokes’ Linked To Kidney Failure In Diabetics
- Immune Cell Levels Predict Skin Cancer Risk In Kidney Transplant Patients
- MRI Reveals Risk for Kidney Failure in Diabetic Patients (CME/CE)
Details :
Submited at Friday, November 13th, 2009 at 7:00 pm on Cancer and Oncology by samantha
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...
















